Two Different Methods of Botulnium Toxin A Injection for Releasing of Hip Adductor Spasticity in Diplegic Children

References (43)

1. 1 Development and reliability of a system to classify gross motor function in children with cerebral palsy [DOI]
2. 2 Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity [DOI]
3. 3 Cerebral Palsy
4. 4 Sagittal gait patterns in spastic diplegia [DOI]
5. 5 Compressive tibiofemoral force during crouch gait [DOI]
6. 6 Ambulatory Physical Activity Performance in Youth With Cerebral Palsy and Youth Who Are Developing Typically [DOI]
7. 7 Changes in cervicocephalic kinesthesia after a proprioceptive rehabilitation program in patients with neck pain: A randomized controlled study [DOI]
8. 8 The Evolution of Gait in Childhood and Adolescent Cerebral Palsy [DOI]
9. 9 Balance control in hemiparetic stroke patients: main tools for evaluation. [DOI]
10. 10 Evaluation of Postural Stability in Children: Current Theories and Assessment Tools [DOI]
11. 11 Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years [DOI]
12. 12 A systematic review of measures of activity limitation for children with cerebral palsy [DOI]
13. 13 Ankle-foot orthoses in children with cerebral palsy: a cross sectional population based study of 2200 children [DOI]
14. 14 Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Lower Extremity Spasticity in Cerebral Palsy: A Randomized, Double-Blind, Placebo-Controlled Trial [DOI]
15. 15 Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy [DOI]
16. 16 Probability of Walking in Children With Cerebral Palsy in Europe [DOI]
17. 17 The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial [DOI]
18. 18 Gait in Children With Cerebral Palsy [DOI]
19. 19 The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb [DOI]
20. 20 Treatment of adductor spasticity with BTX‐A in children with CP: a randomized, double‐blind, placebo‐controlled study [DOI]
21. 21 Occupational therapy for children with cerebral palsy: a systematic review [DOI]
22. 22 Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy [DOI]
23. 23 Changes in muscle activity in children with hemiplegic cerebral palsy while walking with and without ankle–foot orthoses [DOI]
24. 24 The Combined Effect of Lower-Limb Multilevel Botulinum Toxin Type A and Comprehensive Rehabilitation on Mobility in Children With Cerebral Palsy: A Randomized Clinical Trial [DOI]
25. 25 Differences in the dynamic gait stability of children with cerebral palsy and typically developing children [DOI]
26. 26 Drug treatments for spasticity [DOI]
27. 27 Comparison of Spatiotemporal Gait Parameters between Children with Normal Development and Children with Diplegic Cerebral Palsy [DOI]
28. 28 Influence of knee position on the postural stability index registered by the Biodex Stability System [DOI]
29. 29 Management of spasticity [DOI]
30. 30 The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response [DOI]
31. 31 THE MOTOR DEFICIT IN DOWN'S SYNDROME CHILDREN: A PROBLEM OF TIMING? [DOI]
32. 32 Botulinum Toxin A in the Management of Spastic Gait Disorders in Children and Young Adults with Cerebral Palsy: A Randomized, Double-Blind Study of "High-Dose" versus "Low-Dose" Treatment* [DOI]
33. 33 Ankle-foot orthoses: effect on gait in children with cerebral palsy [DOI]
34. 34 Long-term modification of spasticity [DOI]
35. 35 Foot progression angle and ankle joint complex in preschool children [DOI]
36. 36 Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy [DOI]
37. 37 Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
38. 38 Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome [DOI]
39. 39 Use of Botulinum Toxin Type A in Pediatric Patients With Cerebral Palsy: A Three-Center Retrospective Chart Review [DOI]
40. 40 Use of Botulinum Toxin Type A in Children With Cerebral Palsy [DOI]
41. 41 Comparison of the Efficacies of Botulinum Toxin A and Johnstone Pressure Splints against Hip Adductor Spasticity among Patients with Cerebral Palsy: A Randomized Trial [DOI]
42. 42 Motor endplate‐targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy [DOI]
43. 43 The use of botulinum toxin in paediatric hypertonia [DOI]

Cited by 0

No indexed citations yet.

Related research

• Awareness of Botox Injections in Facial Aesthetics among Dental Students — shares topic coverage
• Comparative Analysis of the Effect between FES, RUSSA and AUSSIE Therapeutic Currents in Individuals with Hypertonia Spastic Post Stroke Case Study — shares topic coverage
• Muscle Inhibitory Vs Functional Corrective Kinesio Taping on Gross Motor Functional Abilities in Children with Spastic Cerebral Palsy — shares topic coverage
• Orthopaedic Management in Cerebral Palsy: A Narrative Review — shares topic coverage
• A Review of Efficacy of Hippotherapy for the Treatment of Musculoskeletal Disorders — shares topic coverage